Dr. Daniel Weintraub, MD
Psychiatry (Psychiatry Physician)
At a glance
- Medical school
- University of Maryland School of Medicine (1991)
- Years since graduation
- 35
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1991Medical school: University of Maryland School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Psychiatry Physician primary
PA license MD073913L -
Geriatric Psychiatry Physician
PA license MD073913L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University of Penn - Medical Group (3,505 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
| Service | Times | Patients |
|---|---|---|
| Psychiatric diagnostic evaluation with medical services | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 32 payments worth $143,625 in total to this clinician.
| Eisai Inc. | $101,122 |
|---|---|
| Novo Nordisk As | $20,493 |
| AbbVie Inc. | $9,752 |
| Eli Lilly and Company | $8,412 |
| Boehringer Ingelheim International GmbH | $2,225 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,620 |
| Consulting Fee | $128,732 |
|---|---|
| Travel and Lodging | $14,034 |
| Food and Beverage | $859 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Eisai Inc. Dec 5, 2025 | Consulting Fee Leqembi · Neurology | $24,959 |
| Novo Nordisk As Sep 24, 2025 | Travel and Lodging travel to København, Denmark · in-kind | $11,601 |
| Eisai Inc. Oct 16, 2025 | Consulting Fee Leqembi · Neurology | $9,007 |
| Eisai Inc. Aug 5, 2025 | Consulting Fee Leqembi · Neurology | $9,007 |
| Eisai Inc. Apr 1, 2025 | Consulting Fee Leqembi · Neurology | $8,742 |
| Eisai Inc. Jan 10, 2025 | Consulting Fee Leqembi · Neurology | $8,742 |
| Eisai Inc. Mar 1, 2025 | Consulting Fee Leqembi · Neurology | $8,742 |
| Eisai Inc. Apr 1, 2025 | Consulting Fee Leqembi · Neurology | $7,981 |
| Eisai Inc. Jun 10, 2025 | Consulting Fee Leqembi · Neurology | $7,981 |
| Eisai Inc. Jul 21, 2025 | Consulting Fee Leqembi · Neurology | $7,981 |
All 25 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Dec 11, 2025 | Consulting Fee | $4,725 |
| AbbVie Inc. Dec 11, 2025 | Travel and Lodging travel to PHILADELPHIA, PA · in-kind | $56.00 |
| Eisai Inc. Dec 5, 2025 | Consulting Fee Leqembi · Neurology | $24,959 |
| Eli Lilly and Company Nov 20, 2025 | Consulting FeeCompany’s descriptionSERVICES TO SUPPORT RESEARCH RELATED ACTIVITIES | $7,813 |
| AbbVie Inc. Nov 12, 2025 | Consulting Fee | $4,050 |
| AbbVie Inc. Nov 10, 2025 | Travel and Lodging travel to ROSEMONT, IL · in-kind | $465 |
| AbbVie Inc. Nov 9, 2025 | Travel and Lodging travel to ROSEMONT, IL · in-kind | $238 |
| Eli Lilly and Company Nov 7, 2025 | Travel and Lodging travel to NEW YORK, PA · in-kind | $204 |
| Eli Lilly and Company Nov 7, 2025 | Travel and Lodging travel to NEW YORK, PA · in-kind | $204 |
| Eisai Inc. Oct 16, 2025 | Consulting Fee Leqembi · Neurology | $9,007 |
| Novo Nordisk As Sep 24, 2025 | Travel and Lodging travel to København, Denmark · in-kind | $11,601 |
| Novo Nordisk As Sep 24, 2025 | Consulting Fee | $6,518 |
| Novo Nordisk As Sep 24, 2025 | Travel and Lodging travel to København, Denmark · in-kind | $898 |
| Novo Nordisk As Sep 24, 2025 | Travel and Lodging travel to København, Denmark · in-kind | $369 |
| Novo Nordisk As Sep 8, 2025 | Consulting Fee | $660 |
| Eisai Inc. Aug 5, 2025 | Consulting Fee Leqembi · Neurology | $9,007 |
| Eisai Inc. Jul 21, 2025 | Consulting Fee Leqembi · Neurology | $7,981 |
| Eisai Inc. Jun 10, 2025 | Consulting Fee Leqembi · Neurology | $7,981 |
| Eisai Inc. May 7, 2025 | Consulting Fee Leqembi · Neurology | $7,981 |
| Boehringer Ingelheim International GmbH May 6, 2025 | Consulting Fee | $2,225 |
| Eisai Inc. Apr 1, 2025 | Consulting Fee Leqembi · Neurology | $8,742 |
| Eisai Inc. Apr 1, 2025 | Consulting Fee Leqembi · Neurology | $7,981 |
| Eisai Inc. Mar 1, 2025 | Consulting Fee Leqembi · Neurology | $8,742 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. Jan 24, 2025 | Consulting Fee | $1,620 |
| Eisai Inc. Jan 10, 2025 | Consulting Fee Leqembi · Neurology | $8,742 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.